KeFu Medical (301087.SZ) released its semi-annual report for 2024, and the company achieved revenue of 1... during the reporting period.
KeFu Medical (301087.SZ) released its semi-annual report for 2024, and during the reporting period, the company achieved revenue of 1.559 billion yuan, a year-on-year growth of 2.60%; net income attributable to shareholders of listed company decreased by 7% to 0.185 billion yuan; net income attributable to shareholders of listed company after deducting non-recurring gains and losses decreased by 2.76% to 0.166 billion yuan; basic earnings per share was 0.91 yuan/share.
The profit distribution plan approved by the board of directors of the company is as follows: based on the total equity on the shareholders' registration date for the distribution of equity for the first half of 2024, subtracting the number of shares in the company's repurchase account, the company will distribute a cash dividend of 6 yuan (including tax) to all shareholders for every 10 shares, and no bonus shares (including tax) will be converted from the capital reserve.
